Table of Contents Author Guidelines Submit a Manuscript
Behavioural Neurology
Volume 2015, Article ID 275256, 6 pages
http://dx.doi.org/10.1155/2015/275256
Research Article

Sex Differences in Neuropsychiatric Symptoms of Alzheimer’s Disease: The Modifying Effect of Apolipoprotein E ε4 Status

Yi Xing,1 Yi Tang,1 and Jianping Jia1,2,3,4

1Department of Neurology, Xuan Wu Hospital, Capital Medical University, Beijing 100053, China
2Center of Alzheimer’s Disease, Beijing Institute for Brain Disorders, Beijing 100069, China
3Beijing Key Laboratory of Geriatric Cognitive Disorders, Beijing 100053, China
4Neurodegenerative Laboratory of Ministry of Education of the People’s Republic of China, Beijing 100053, China

Received 23 June 2015; Revised 8 September 2015; Accepted 9 September 2015

Academic Editor: Hrayr Attarian

Copyright © 2015 Yi Xing et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. Ikeda, K. Shigenobu, R. Fukuhara et al., “Delusions of Japanese patients with Alzheimer's disease,” International Journal of Geriatric Psychiatry, vol. 18, no. 6, pp. 527–532, 2003. View at Publisher · View at Google Scholar · View at Scopus
  2. S. Banerjee, S. C. Smith, D. L. Lamping et al., “Quality of life in dementia: More than just cognition. An analysis of associations with quality of life in dementia,” Journal of Neurology, Neurosurgery and Psychiatry, vol. 77, no. 2, pp. 146–148, 2006. View at Publisher · View at Google Scholar · View at Scopus
  3. N. Matsumoto, M. Ikeda, R. Fukuhara et al., “Caregiver burden associated with behavioral and psychological symptoms of dementia in elderly people in the local community,” Dementia and Geriatric Cognitive Disorders, vol. 23, no. 4, pp. 219–224, 2007. View at Publisher · View at Google Scholar · View at Scopus
  4. M. E. Peters, S. Schwartz, D. Han et al., “Neuropsychiatric symptoms as predictors of progression to severe alzheimer's dementia and death: The cache county dementia progression study,” American Journal of Psychiatry, vol. 172, no. 5, pp. 460–465, 2015. View at Publisher · View at Google Scholar
  5. S.-M. Tun, D. L. Murman, H. L. Long, C. C. Colenda, and A. von Eye, “Predictive validity of neuropsychiatric subgroups on nursing home placement and survival in patients with alzheimer disease,” The American Journal of Geriatric Psychiatry, vol. 15, no. 4, pp. 314–327, 2007. View at Publisher · View at Google Scholar · View at Scopus
  6. B. R. Ott, C. A. Tate, N. M. Gordon, and W. C. Heindel, “Gender differences in the behavioral manifestations of Alzheimer's disease,” Journal of the American Geriatrics Society, vol. 44, no. 5, pp. 583–587, 1996. View at Publisher · View at Google Scholar · View at Scopus
  7. S. A. Ropacki and D. V. Jeste, “Epidemiology of and risk factors for psychosis of Alzheimer's disease: a review of 55 studies published from 1990 to 2003,” The American Journal of Psychiatry, vol. 162, no. 11, pp. 2022–2030, 2005. View at Publisher · View at Google Scholar · View at Scopus
  8. S. U. Zuidema, J. F. M. de Jonghe, F. R. J. Verhey, and R. T. C. M. Koopmans, “Predictors of neuropsychiatric symptoms in nursing home patients: influence of gender and dementia severity,” International Journal of Geriatric Psychiatry, vol. 24, no. 10, pp. 1079–1086, 2009. View at Publisher · View at Google Scholar · View at Scopus
  9. B. R. Ott, K. L. Lapane, and G. Gambassi, “Gender differences in the treatment of behavior problems in Alzheimer's disease,” Neurology, vol. 54, no. 2, pp. 427–432, 2000. View at Publisher · View at Google Scholar · View at Scopus
  10. W. M. van der Flier, S. Staekenborg, Y. A. L. Pijnenburg et al., “Apolipoprotein E genotype influences presence and severity of delusions and aggressive behavior in Alzheimer disease,” Dementia and Geriatric Cognitive Disorders, vol. 23, no. 1, pp. 42–46, 2006. View at Publisher · View at Google Scholar · View at Scopus
  11. F. Panza, V. Frisardi, D. Seripa et al., “Apolipoprotein E genotypes and neuropsychiatric symptoms and syndromes in late-onset Alzheimer's disease,” Ageing Research Reviews, vol. 11, no. 1, pp. 87–103, 2012. View at Publisher · View at Google Scholar · View at Scopus
  12. A. Michels, M. Multhammer, M. Zintl, M. C. Mendoza, and H.-H. Klünemann, “Association of apolipoprotein E ε4 (ApoE ε4) homozygosity with psychiatric behavioral symptoms,” Journal of Alzheimer's Disease, vol. 28, no. 1, pp. 25–32, 2012. View at Publisher · View at Google Scholar · View at Scopus
  13. L. Ungar, A. Altmann, and M. D. Greicius, “Apolipoprotein E, gender, and Alzheimer's disease: an overlooked, but potent and promising interaction,” Brain Imaging and Behavior, vol. 8, no. 2, pp. 262–273, 2014. View at Publisher · View at Google Scholar · View at Scopus
  14. Y. Xing, W. Qin, F. Li, X.-F. Jia, and J. Jia, “Apolipoprotein E ε4 status modifies the effects of sex hormones on neuropsychiatric symptoms of Alzheimer's disease,” Dementia and Geriatric Cognitive Disorders, vol. 33, no. 1, pp. 35–42, 2012. View at Publisher · View at Google Scholar · View at Scopus
  15. Y. Xing, C. Wei, C. Chu et al., “Stage-specific gender differences in cognitive and neuropsychiatric manifestations of vascular dementia,” American Journal of Alzheimer's Disease and other Dementias, vol. 27, no. 6, pp. 433–438, 2012. View at Publisher · View at Google Scholar · View at Scopus
  16. M. F. Folstein, S. E. Folstein, and P. R. McHugh, “‘Mini-mental state’. A practical method for grading the cognitive state of patients for the clinician,” Journal of Psychiatric Research, vol. 12, no. 3, pp. 189–198, 1975. View at Publisher · View at Google Scholar · View at Scopus
  17. J. C. Morris, “The Clinical Dementia Rating (CDR): current version and scoring rules,” Neurology, vol. 43, no. 11, pp. 2412–2414, 1993. View at Google Scholar · View at Scopus
  18. J. L. Cummings, M. Mega, K. Gray, S. Rosenberg-Thompson, D. A. Carusi, and J. Gornbein, “The neuropsychiatric inventory: comprehensive assessment of psychopathology in dementia,” Neurology, vol. 44, no. 12, pp. 2308–2314, 1994. View at Publisher · View at Google Scholar · View at Scopus
  19. M.-S. Tsai, E. G. Tangalos, R. C. Petersen et al., “Apolipoprotein E: risk factor for Alzheimer disease,” American Journal of Human Genetics, vol. 54, no. 4, pp. 643–649, 1994. View at Google Scholar · View at Scopus
  20. P. S. Murray, C. M. Kirkwood, M. C. Gray et al., “Hyperphosphorylated tau is elevated in Alzheimer's disease with psychosis,” Journal of Alzheimer's Disease, vol. 39, no. 4, pp. 759–773, 2014. View at Publisher · View at Google Scholar · View at Scopus
  21. I. H. G. B. Ramakers, F. R. J. Verhey, P. Scheltens et al., “Anxiety is related to Alzheimer cerebrospinal fluid markers in subjects with mild cognitive impairment,” Psychological Medicine, vol. 43, no. 5, pp. 911–920, 2013. View at Publisher · View at Google Scholar · View at Scopus
  22. E. H. Corder, E. Ghebremedhin, M. G. Taylor, D. R. Thal, T. G. Ohm, and H. Braak, “The biphasic relationship between regional brain senile plaque and neurofibrillary tangle distributions: modification by age, sex, and APOE polymorphism,” Annals of the New York Academy of Sciences, vol. 1019, pp. 24–28, 2004. View at Publisher · View at Google Scholar · View at Scopus
  23. J. S. Damoiseaux, W. W. Seeley, J. Zhou et al., “Gender modulates the APOEε4 effect in healthy older adults: convergent evidence from functional brain connectivity and spinal fluid tau levels,” The Journal of Neuroscience, vol. 32, no. 24, pp. 8254–8262, 2012. View at Publisher · View at Google Scholar · View at Scopus
  24. P. T. Trzepacz, P. Yu, P. K. Bhamidipati et al., “Frontolimbic atrophy is associated with agitation and aggression in mild cognitive impairment and Alzheimer's disease,” Alzheimer's & Dementia, vol. 9, no. 5, pp. S95.e1–S104.e1, 2013. View at Publisher · View at Google Scholar · View at Scopus
  25. S. P. Poulin, R. Dautoff, J. C. Morris, L. F. Barrett, and B. C. Dickerson, “Amygdala atrophy is prominent in early Alzheimer's disease and relates to symptom severity,” Psychiatry Research—Neuroimaging, vol. 194, no. 1, pp. 7–13, 2011. View at Publisher · View at Google Scholar · View at Scopus
  26. A. Fleisher, M. Grundman, C. R. Jack Jr. et al., “Sex, apolipoprotein E ε4 status, and hippocampal volume in mild cognitive impairment,” Archives of Neurology, vol. 62, no. 6, pp. 953–957, 2005. View at Publisher · View at Google Scholar · View at Scopus
  27. Y. A. Berlow, W. M. Wells, J. M. Ellison, Y. H. Sung, P. F. Renshaw, and D. G. Harper, “Neuropsychiatric correlates of white matter hyperintensities in Alzheimer's disease,” International Journal of Geriatric Psychiatry, vol. 25, no. 8, pp. 780–788, 2010. View at Publisher · View at Google Scholar · View at Scopus
  28. V. Heise, N. Filippini, A. J. Trachtenberg, S. Suri, K. P. Ebmeier, and C. E. Mackay, “Apolipoprotein E genotype, gender and age modulate connectivity of the hippocampus in healthy adults,” NeuroImage, vol. 98, pp. 23–30, 2014. View at Publisher · View at Google Scholar · View at Scopus
  29. S. Whitfield-Gabrieli and J. M. Ford, “Default mode network activity and connectivity in psychopathology,” Annual Review of Clinical Psychology, vol. 8, pp. 49–76, 2012. View at Publisher · View at Google Scholar · View at Scopus
  30. M. L. F. Balthazar, F. R. S. Pereira, T. M. Lopes et al., “Neuropsychiatric symptoms in Alzheimer's disease are related to functional connectivity alterations in the salience network,” Human Brain Mapping, vol. 35, no. 4, pp. 1237–1246, 2014. View at Publisher · View at Google Scholar · View at Scopus